Related Experiment Video
Updated: Jul 19, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Gankyrin, the 26 S proteasome, the cell cycle and cancer
1School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK. John.Mayer@nottingham.ac.uk
Abstract:
The known molecular players in cell-cycle control are much studied, not only to learn more about this intricate system, but also to understand the molecular features of oncogenic transformation. Infrequently, new players are discovered that change the interpretation of cell-cycle control. Gankyrin is one such player and was discovered in yeast two-hybrid screens as a new proteasomal subunit that interacts specifically with the S6b (rpt3) AAA (ATPase associated with various cellular activities) ATPase, which, with five other AAAs, are present in the so-called base of the 19 S regulator of the 26 S proteasome. Gankyrin is also the first liver oncogene. Gankyrin is found in other complexes that contain Rb (retinoblastoma protein) and the ubiquitin protein ligase Mdm2 (murine double minute 2). Gankyrin increases the hyperphosphorylation of Rb and therefore activates E2F-dependent transcription of DNA synthesis genes. Additionally, gankyrin, by binding to Mdm2, increases the ubiquitylation and degradation of p53 and prevents apoptosis. Gankyrin controls the functions of two major tumour suppressors and, when overexpressed, causes hepatocellular carcinoma.
Insights
Gankyrin, a novel proteasomal subunit and liver oncogene, disrupts cell-cycle control by affecting Rb and p53 tumor suppressors. Its overexpression leads to hepatocellular carcinoma.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Cell-cycle control is crucial for understanding normal cellular processes and oncogenic transformation.
- New molecular players continually emerge, refining our understanding of cell-cycle regulation.
- Gankyrin is identified as a novel proteasomal subunit with significant implications in cancer.
Purpose of the Study:
- To elucidate the role of gankyrin in cell-cycle control and oncogenesis.
- To investigate gankyrin's interactions with key regulatory proteins like Rb and Mdm2.
- To understand how gankyrin contributes to hepatocellular carcinoma development.
Main Methods:
- Yeast two-hybrid screens to identify gankyrin's interacting partners.
- Analysis of gankyrin's role in proteasome regulation.
- Investigation of gankyrin's effects on retinoblastoma protein (Rb) phosphorylation and p53 degradation.
Main Results:
- Gankyrin interacts with the S6b (Rpt3) AAA ATPase subunit of the 26S proteasome.
- Gankyrin promotes Rb hyperphosphorylation, activating E2F-dependent DNA synthesis genes.
- Gankyrin enhances Mdm2-mediated ubiquitylation and degradation of p53, inhibiting apoptosis.
Conclusions:
- Gankyrin functions as a liver oncogene by manipulating critical tumor suppressor pathways.
- Gankyrin's aberrant activity disrupts cell-cycle checkpoints and promotes uncontrolled cell proliferation.
- Targeting gankyrin may offer therapeutic strategies for hepatocellular carcinoma.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
The Cell Cycle Control System
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules

